Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Videira, I.F.; Moura, D.F.; Magina, S. Mechanisms regulating melanogenesis. An. Bras. Dermatol. 2013, 88, 76–83. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pss, R.; Madhunapantula, S.V.; Betkerur, J.B.; Bovilla, V.R.; Shastry, V. Melanogenesis Markers Expression in Premature Graying of Hair: A Cross-Sectional Study. Skin Pharmacol. Physiol. 2022, 35, 180–186. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Juhasz, M.; Conic, R.R.Z.; Atanaskova Mesinkovska, N. Hair Follicle Melanogenesis Reflected in Hair Pigmentation as a Developmental Factor in Alopecia Areata. Skin Appendage Disord. 2021, 7, 370–372. [Google Scholar] [CrossRef] [Scilit]
- Ito, S.; Wakamatsu, K. Diversity of human hair pigmentation as studied by chemical analysis of eumelanin and pheomelanin. J. Eur. Acad. Dermatol. Venereol. 2011, 25, 1369–1380. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wielgus, A.R.; Sarna, T. Melanin in human irides of different color and age of donors. Pigment Cell Res. 2005, 18, 454–464. [Google Scholar] [CrossRef] [Scilit]
- Hushcha, Y.; Blo, I.; Oton-Gonzalez, L.; Mauro, G.D.; Martini, F.; Tognon, M.; Mattei, M. microRNAs in the Regulation of Melanogenesis. Int. J. Mol. Sci. 2021, 22, 6104. [Google Scholar] [CrossRef] [Scilit]
- Zecca, L.; Tampellini, D.; Gerlach, M.; Riederer, P.; Fariello, R.G.; Sulzer, D. Substantia nigra neuromelanin: Structure, synthesis, and molecular behaviour. Mol. Pathol. 2001, 54, 414–418. [Google Scholar]
- Capucciati, A.; Zucca, F.A.; Monzani, E.; Zecca, L.; Casella, L.; Hofer, T. Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models. Antioxidants 2021, 10, 824. [Google Scholar] [CrossRef] [Scilit]
- Ishikuro, K.; Hattori, N.; Imanishi, R.; Furuya, K.; Nakata, T.; Dougu, N.; Yamamoto, M.; Konishi, H.; Nukui, T.; Hayashi, T.; et al. A Parkinson’s disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: A case report. Neurocase 2021, 27, 407–414. [Google Scholar] [CrossRef] [Scilit]
- Derby, C.D. Cephalopod ink: Production, chemistry, functions and applications. Mar. Drugs 2014, 12, 2700–2730. [Google Scholar] [CrossRef] [Scilit]
- Zecca, L.; Stroppolo, A.; Gatti, A.; Tampellini, D.; Toscani, M.; Gallorini, M.; Giaveri, G.; Arosio, P.; Santambrogio, P.; Fariello, R.G.; et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl. Acad. Sci. USA 2004, 101, 9843–9848. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Stepien, K.; Dzierzega-Lecznar, A.; Tam, I. The role of neuromelanin in Parkinson’s disease—New concepts. Wiad. Lek. 2007, 60, 563–569. [Google Scholar] [PubMed]
- Zecca, L.; Wilms, H.; Geick, S.; Claasen, J.H.; Brandenburg, L.O.; Holzknecht, C.; Panizza, M.L.; Zucca, F.A.; Deuschl, G.; Sievers, J.; et al. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: Implications for Parkinson’s disease. Acta Neuropathol. 2008, 116, 47–55. [Google Scholar] [CrossRef] [Scilit]
- Juceviciute, N.; Banaityte, I.; Vaitkus, A.; Balnyte, R. Preclinical signs of Parkinson’s disease: A possible association of Parkinson’s disease with skin and hair features. Med. Hypotheses 2019, 127, 100–104. [Google Scholar] [CrossRef] [Scilit]
- Miyamura, Y.; Coelho, S.G.; Wolber, R.; Miller, S.A.; Wakamatsu, K.; Zmudzka, B.Z.; Ito, S.; Smuda, C.; Passeron, T.; Choi, W.; et al. Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res. 2007, 20, 2–13. [Google Scholar] [CrossRef] [Scilit]
- Szabo, G. The number of melanocytes in human epidermis. Br. Med. J. 1954, 1, 1016–1017. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lakhan, M.K.; Lynch, L. Skin pigmentation. Medicine 2021, 49, 447–452. [Google Scholar] [CrossRef] [Scilit]
- Hadley, M.E.; Haskell-Luevano, C. The proopiomelanocortin system. Ann. N. Y. Acad. Sci. 1999, 885, 1–21. [Google Scholar] [CrossRef] [Scilit]
- Slominski, A. Neuroendocrine activity of the melanocyte. Exp. Dermatol. 2009, 18, 760–763. [Google Scholar] [CrossRef] [Scilit]
- Abdel-Malek, Z.; Scott, M.C.; Suzuki, I.; Tada, A.; Im, S.; Lamoreux, L.; Ito, S.; Barsh, G.; Hearing, V.J. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res. 2000, 13 (Suppl. 8), 156–162. [Google Scholar] [CrossRef] [Scilit]
- Alaluf, S.; Atkins, D.; Barrett, K.; Blount, M.; Carter, N.; Heath, A. Ethnic variation in melanin content and composition in photoexposed and photoprotected human skin. Pigment Cell Res. 2002, 15, 112–118. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Naik, P.P.; Farrukh, S.N. Influence of Ethnicities and Skin Color Variations in Different Populations: A Review. Skin Pharmacol. Physiol. 2022, 35, 65–76. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sitek, A.; Zadzinska, E.; Rosset, I.; Antoszewski, B. Is increased constitutive skin and hair pigmentation an early sign of puberty? Homo 2013, 64, 205–214. [Google Scholar] [CrossRef] [Scilit]
- Sitek, A.; Rosset, I.; Zadzinska, E.; Siewierska-Gorska, A.; Pietrowska, E.; Strapagiel, D. Selected gene polymorphisms effect on skin and hair pigmentation in Polish children at the prepubertal age. Anthropol. Anz. 2016, 73, 283–293. [Google Scholar] [CrossRef] [Scilit]
- D’Orazio, J.; Jarrett, S.; Amaro-Ortiz, A.; Scott, T. UV radiation and the skin. Int. J. Mol. Sci. 2013, 14, 12222–12248. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Levine, J.A.; Sorace, M.; Spencer, J.; Siegel, D.M. The indoor UV tanning industry: A review of skin cancer risk, health benefit claims, and regulation. J. Am. Acad. Dermatol. 2005, 53, 1038–1044. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rumpf, J.J.; Schirmer, M.; Fricke, C.; Weise, D.; Wagner, J.A.; Simon, J.; Classen, J. Light pigmentation phenotype is correlated with increased substantia nigra echogenicity. Mov. Disord. 2015, 30, 1848–1852. [Google Scholar] [CrossRef] [Scilit]
- Disse, M.; Reich, H.; Lee, P.K.; Schram, S.S. A Review of the Association Between Parkinson Disease and Malignant Melanoma. Dermatol. Surg. 2016, 42, 141–146. [Google Scholar] [CrossRef] [Scilit]
- Herrero Hernandez, E. Pigmentation genes link Parkinson’s disease to melanoma, opening a window on both etiologies. Med. Hypotheses 2009, 72, 280–284. [Google Scholar] [CrossRef] [Scilit]
- Chen, X.; Feng, D.; Schwarzschild, M.A.; Gao, X. Red hair, MC1R variants, and risk for Parkinson’s disease—A meta-analysis. Ann. Clin. Transl. Neurol. 2017, 4, 212–216. [Google Scholar] [CrossRef] [Scilit]
- Puig-Butille, J.A.; Escamez, M.J.; Garcia-Garcia, F.; Tell-Marti, G.; Fabra, A.; Martinez-Santamaria, L.; Badenas, C.; Aguilera, P.; Pevida, M.; Dopazo, J.; et al. Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer. Oncotarget 2014, 5, 1439–1451. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Robinson, K.C.; Kemeny, L.V.; Fell, G.L.; Hermann, A.L.; Allouche, J.; Ding, W.; Yekkirala, A.; Hsiao, J.J.; Su, M.Y.; Theodosakis, N.; et al. Reduced MC4R signaling alters nociceptive thresholds associated with red hair. Sci. Adv. 2021, 7, eabd1310. [Google Scholar] [CrossRef] [Scilit]
- Collaborators, G.B.D.H. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018, 17, 954–976. [Google Scholar] [CrossRef] [Scilit]
- Disease, G.B.D.; Injury, I.; Prevalence, C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1545–1602. [Google Scholar] [CrossRef] [Scilit]
- Fitzgerald, M.C.; Saelzler, U.G.; Panizzon, M.S. Sex Differences in Migraine: A Twin Study. Front. Pain. Res. 2021, 2, 766718. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mulder, E.J.; Van Baal, C.; Gaist, D.; Kallela, M.; Kaprio, J.; Svensson, D.A.; Nyholt, D.R.; Martin, N.G.; MacGregor, A.J.; Cherkas, L.F.; et al. Genetic and environmental influences on migraine: A twin study across six countries. Twin. Res. 2003, 6, 422–431. [Google Scholar] [CrossRef]
- Kobus, M.; Sitek, A.; Antoszewski, B.; Rozniecki, J.; Pelka, J.; Zadzinska, E. Prenatal oestrogen-testosterone balance as a risk factor of migraine in adults. J. Headache Pain. 2021, 22, 119. [Google Scholar] [CrossRef] [Scilit]
- Silberstein, S.D. Migraine. Lancet 2004, 363, 381–391. [Google Scholar] [CrossRef] [Scilit]
- Khan, J.; Asoom, L.I.A.; Sunni, A.A.; Rafique, N.; Latif, R.; Saif, S.A.; Almandil, N.B.; Almohazey, D.; AbdulAzeez, S.; Borgio, J.F. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed. Pharmacother. 2021, 139, 111557. [Google Scholar] [CrossRef] [Scilit]
- IHS. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018, 38, 1–211. [Google Scholar] [CrossRef] [Scilit]
- Ashina, M.; Katsarava, Z.; Do, T.P.; Buse, D.C.; Pozo-Rosich, P.; Ozge, A.; Krymchantowski, A.V.; Lebedeva, E.R.; Ravishankar, K.; Yu, S.; et al. Migraine: Epidemiology and systems of care. Lancet 2021, 397, 1485–1495. [Google Scholar] [CrossRef] [Scilit]
- Dai, Y.X.; Tai, Y.H.; Chen, C.C.; Chang, Y.T.; Chen, T.J.; Chen, M.H. Bidirectional association between alopecia areata and migraine: A nationwide population-based cohort study. J. Am. Acad. Dermatol. 2021, 85, 254–256. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Silverberg, J.I. Association between childhood eczema and headaches: An analysis of 19 US population-based studies. J. Allergy Clin. Immunol. 2016, 137, 492–499.e495. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Steuer, A.B.; Cohen, J.M.; Wong, P.W.; Ho, R.S. Psoriasis and the risk of migraines in the United States. J. Am. Acad. Dermatol. 2020, 82, 1225–1226. [Google Scholar] [CrossRef] [Scilit]
- Sinikumpu, S.P.; Vahanikkila, H.; Jokelainen, J.; Tasanen, K.; Huilaja, L. Male patients with rosacea have increased risk for migraine: A population-based study. Br. J. Dermatol. 2021, 185, 1058–1061. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Egeberg, A.; Ashina, M.; Gaist, D.; Gislason, G.H.; Thyssen, J.P. Prevalence and risk of migraine in patients with rosacea: A population-based cohort study. J. Am. Acad. Dermatol. 2017, 76, 454–458. [Google Scholar] [CrossRef] [Scilit]
- Christensen, C.E.; Andersen, F.S.; Wienholtz, N.; Egeberg, A.; Thyssen, J.P.; Ashina, M. The relationship between migraine and rosacea: Systematic review and meta-analysis. Cephalalgia 2018, 38, 1387–1398. [Google Scholar] [CrossRef] [Scilit]
- Crawford, P.F. Migraine equivalent in the skin. Br. J. Dermatol. 1961, 73, 419–420. [Google Scholar] [CrossRef] [Scilit]
- Berdouk, S.; Khan, S. Migraine with extensive skin markings: A case report. Int. J. Emerg. Med. 2018, 11, 32. [Google Scholar] [CrossRef] [Scilit]
- Durmaz, E.O.a.C.D. Red forehead dot(s) and migraine. Indian J. Dermatol. Venereol. Leprol. 2020, 86, 704–705. [Google Scholar] [CrossRef] [Scilit]
- Sitek, A.; Rosset, I.; Zadzinska, E.; Kasielska-Trojan, A.; Neskoromna-Jedrzejczak, A.; Antoszewski, B. Skin color parameters and Fitzpatrick phototypes in estimating the risk of skin cancer: A case-control study in the Polish population. J. Am. Acad. Dermatol. 2016, 74, 716–723. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Taylor, S.; Westerhof, W.; Im, S.; Lim, J. Noninvasive techniques for the evaluation of skin color. J. Am. Acad. Dermatol. 2006, 54, S282–S290. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Masuda, Y.; Yamashita, T.; Hirao, T.; Takahashi, M. An innovative method to measure skin pigmentation. Skin Res. Technol. 2009, 15, 224–229. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fitzpatrick, T.B. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1988, 124, 869–871. [Google Scholar] [CrossRef] [Scilit]
- Falcon, K.; Fors, M.; Palacios Alvarez, S.; Veintimilla, K.; Lasso, N.; Navas, C. Assessment of Predictors of Sun Sensitivity as Defined by Fitzpatrick Skin Phototype in an Ecuadorian Population and Its Correlation with Skin Damage. Dermatology 2019, 235, 400–406. [Google Scholar] [CrossRef] [Scilit]
- Pershing, L.K.; Tirumala, V.P.; Nelson, J.L.; Corlett, J.L.; Lin, A.G.; Meyer, L.J.; Leachman, S.A. Reflectance spectrophotometer: The dermatologists’ sphygmomanometer for skin phototyping? J. Investig. Dermatol. 2008, 128, 1633–1640. [Google Scholar] [CrossRef] [Scilit]
- Hail, C.U.; Schnoering, G.; Damak, M.; Poulikakos, D.; Eghlidi, H. A Plasmonic Painter’s Method of Color Mixing for a Continuous Red-Green-Blue Palette. ACS Nano 2020, 14, 1783–1791. [Google Scholar] [CrossRef] [Scilit]
- Ashina, M.; Buse, D.C.; Ashina, H.; Pozo-Rosich, P.; Peres, M.F.P.; Lee, M.J.; Terwindt, G.M.; Halker Singh, R.; Tassorelli, C.; Do, T.P.; et al. Migraine: Integrated approaches to clinical management and emerging treatments. Lancet 2021, 397, 1505–1518. [Google Scholar] [CrossRef] [Scilit]
- Ashina, M.; Terwindt, G.M.; Al-Karagholi, M.A.; de Boer, I.; Lee, M.J.; Hay, D.L.; Schulte, L.H.; Hadjikhani, N.; Sinclair, A.J.; Ashina, H.; et al. Migraine: Disease characterisation, biomarkers, and precision medicine. Lancet 2021, 397, 1496–1504. [Google Scholar] [CrossRef] [Scilit]
- Tseng, W.P. Effects and dose—Response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 1977, 19, 109–119. [Google Scholar] [CrossRef]
- Chen, Y.C.; Guo, Y.L.; Su, H.J.; Hsueh, Y.M.; Smith, T.J.; Ryan, L.M.; Lee, M.S.; Chao, S.C.; Lee, J.Y.; Christiani, D.C. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 2003, 45, 241–248. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Memon, A.; Bannister, P.; Rogers, I.; Sundin, J.; Al-Ayadhy, B.; James, P.W.; McNally, R.J.Q. Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018. Lancet Reg. Health Eur. 2021, 2, 100024. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fijalkowska, M.; Koziej, M.; Antoszewski, B. Detailed head localization and incidence of skin cancers. Sci. Rep. 2021, 11, 12391. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kricker, A.; Armstrong, B.K.; English, D.R.; Heenan, P.J. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer—A case-control study. Int. J. Cancer 1991, 48, 650–662. [Google Scholar] [CrossRef] [Scilit]
- Nasti, T.H.; Timares, L. MC1R, eumelanin and pheomelanin: Their role in determining the susceptibility to skin cancer. Photochem. Photobiol. 2015, 91, 188–200. [Google Scholar] [CrossRef] [Scilit]
- Ono, K.; Viet, C.T.; Ye, Y.; Dang, D.; Hitomi, S.; Toyono, T.; Inenaga, K.; Dolan, J.C.; Schmidt, B.L. Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling. Sci. Rep. 2017, 7, 9181. [Google Scholar] [CrossRef] [Scilit]
- Freilinger, T.; Anttila, V.; de Vries, B.; Malik, R.; Kallela, M.; Terwindt, G.M.; Pozo-Rosich, P.; Winsvold, B.; Nyholt, D.R.; van Oosterhout, W.P.; et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet. 2012, 44, 777–782. [Google Scholar] [CrossRef] [Scilit]
- Nealen, M.L.; Gold, M.S.; Thut, P.D.; Caterina, M.J. TRPM8 mRNA is expressed in a subset of cold-responsive trigeminal neurons from rat. J. Neurophysiol. 2003, 90, 515–520. [Google Scholar] [CrossRef] [Scilit]
- Key, F.M.; Abdul-Aziz, M.A.; Mundry, R.; Peter, B.M.; Sekar, A.; D’Amato, M.; Dennis, M.Y.; Schmidt, J.M.; Andres, A.M. Human local adaptation of the TRPM8 cold receptor along a latitudinal cline. PLoS Genet. 2018, 14, e1007298. [Google Scholar] [CrossRef] [Scilit]
- WHO. Atlas of Headache Disorders and Resources in the World 2011; World Health Organization: Geneva, Switzerland, 2011. Available online: https://apps.who.int/iris/handle/10665/44571 (accessed on 1 December 2021).
- Jablonski, N.G.; Chaplin, G. The colours of humanity: The evolution of pigmentation in the human lineage. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2017, 372, 20160349. [Google Scholar] [CrossRef] [Scilit]
- McNamara, M.E.; Rossi, V.; Slater, T.S.; Rogers, C.S.; Ducrest, A.L.; Dubey, S.; Roulin, A. Decoding the Evolution of Melanin in Vertebrates. Trends Ecol. Evol. 2021, 36, 430–443. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Marmura, M.J. Triggers, Protectors, and Predictors in Episodic Migraine. Curr. Pain Headache Rep. 2018, 22, 81. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Maniyar, F.H.; Sprenger, T.; Schankin, C.; Goadsby, P.J. Photic hypersensitivity in the premonitory phase of migraine—A positron emission tomography study. Eur. J. Neurol. 2014, 21, 1178–1183. [Google Scholar] [CrossRef] [Scilit] [PubMed]
| Variable | FEMALES | Student t-Test * | ||
|---|---|---|---|---|
| Migraine Group N = 115 | Control Group N = 64 | t | p | |
| Age | 42.55 ± 14.18 | 43.73 ± 14.65 | −0.53 | 0.597 |
| MI | 27.08 ± 2.81 | 28.57 ± 3.25 | −3.21 | 0.002 |
| EI | 9.26 ± 1.65 | 10.27 ± 1.90 | −3.73 | 0.000 |
| L* | 45.99 ± 3.96 | 43.99 ± 4.11 | 3.21 | 0.002 |
| a* | 13.61 ± 1.75 | 14.61 ± 1.96 | −3.52 | 0.001 |
| b* | 16.12 ± 3.04 | 16.17 ± 3.44 | −0.11 | 0.913 |
| R | 137.01 ± 8.60 | 132.58 ± 9.70 | 3.15 | 0.002 |
| G | 111.07 ± 11.83 | 105.24 ± 11.23 | 3.22 | 0.002 |
| B | 106.27 ± 12.34 | 100.27 ± 13.90 | 2.98 | 0.003 |
| Variable | MALES | Student t-Test * | ||
|---|---|---|---|---|
| Migraine Group N = 33 | Control Group N = 43 | t | p | |
| Age | 41.52 ± 15.72 | 41.07 ± 13.70 | 0.13 | 0.896 |
| MI | 27.07 ± 2.30 | 28.27 ± 2.38 | −2.21 | 0.030 |
| EI | 9.66 ± 1.63 | 10.45 ± 2.10 | −1.78 | 0.080 |
| L* | 45.55 ± 3.31 | 44.00 ± 3.45 | 1.98 | 0.051 |
| a* | 14.72 ± 2.52 | 15.14 ± 2.80 | −0.68 | 0.500 |
| b* | 14.78 ± 2.68 | 16.74 ± 5.29 | −2.10 | 0.039 |
| R | 137.08 ± 7.33 | 133.26 ± 7.32 | 2.25 | 0.028 |
| G | 109.88 ± 8.78 | 105.45 ± 9.62 | 2.06 | 0.043 |
| B | 104.89 ± 12.06 | 100.21 ± 12.96 | 1.61 | 0.112 |
| Dependent Variable | Independent Variable | Covariate | partial η2Group | ||
|---|---|---|---|---|---|
| Study Group | Age | ||||
| F | p | F | p | ||
| MI | 10.01 | 0.002 | 1.5 | 0.222 | 0.05 |
| EI | 13.72 | 0.000 | 0.08 | 0.778 | 0.07 |
| L* | 9.96 | 0.002 | 1.97 | 0.162 | 0.05 |
| a* | 12.49 | 0.001 | 0.41 | 0.525 | 0.07 |
| b* | 0.31 | 0.581 | 0.01 | 0.931 | 0.00 |
| R | 9.63 | 0.002 | 1.84 | 0.177 | 0.05 |
| G | 10.15 | 0.002 | 0.24 | 0.622 | 0.05 |
| B | 8.62 | 0.004 | 0.95 | 0.331 | 0.05 |
| Dependent Variable | Independent Variable | Covariate | partial η2Group | ||
|---|---|---|---|---|---|
| Study Group | Age | ||||
| F | p | F | p | ||
| MI | 4.80 | 0.032 | 0.34 | 0.561 | 0.06 |
| EI | 3.28 | 0.074 | 7.56 | 0.008 | 0.04 |
| L* | 3.89 | 0.052 | 2.16 | 0.146 | 0.05 |
| a* | 0.44 | 0.508 | 7.59 | 0.007 | 0.01 |
| b* | 3.72 | 0.058 | 1.17 | 0.283 | 0.05 |
| R | 4.97 | 0.029 | 0.18 | 0.672 | 0.06 |
| G | 4.24 | 0.043 | 2.36 | 0.129 | 0.05 |
| B | 2.59 | 0.112 | 3.87 | 0.053 | 0.03 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kobus, M.; Żądzińska, E.; Sitek, A.; Pełka, J.; Rożniecki, J.J.; Antoszewski, B. Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study. Brain Sci. 2022, 12, 620. https://doi.org/10.3390/brainsci12050620
Kobus M, Żądzińska E, Sitek A, Pełka J, Rożniecki JJ, Antoszewski B. Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study. Brain Sciences. 2022; 12(5):620. https://doi.org/10.3390/brainsci12050620
Chicago/Turabian StyleKobus, Magdalena, Elżbieta Żądzińska, Aneta Sitek, Jacek Pełka, Jacek J. Rożniecki, and Bogusław Antoszewski. 2022. "Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study" Brain Sciences 12, no. 5: 620. https://doi.org/10.3390/brainsci12050620
APA StyleKobus, M., Żądzińska, E., Sitek, A., Pełka, J., Rożniecki, J. J., & Antoszewski, B. (2022). Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study. Brain Sciences, 12(5), 620. https://doi.org/10.3390/brainsci12050620

